Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 27.46% vs 55.03% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 41.47% vs 320.46% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 18.72% vs 193.04% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -66.67% vs 150.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Shenyang Xingqi Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 20.07% vs -23.20% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 27.46% vs 55.03% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 113.00% vs -63.31% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 41.47% vs 320.46% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 56.86% vs -56.86% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 18.72% vs 193.04% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -16.67% vs -40.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -66.67% vs 150.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






